Affinage

ARL6IP6

ADP-ribosylation factor-like protein 6-interacting protein 6 · UniProt Q8N6S5

Length
226 aa
Mass
24.7 kDa
Annotated
2026-06-09
7 papers in source corpus 1 papers cited in narrative 1 extracted findings
Cross-family judge faithfulness: 1/1 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ARL6IP6 is a transmembrane protein concentrated at the nuclear envelope, likely residing in the inner nuclear membrane, as established by organellar proteomics enrichment scoring and quantitative immunofluorescence across mesenchymal stem cells, adipocytes, and myocytes (PMID:31142202). Beyond this localization, no molecular function, binding partner, or pathway role for ARL6IP6 has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 1 step
  1. 2019 Medium

    Where ARL6IP6 resides in the cell was unknown; combining subcellular fractionation with quantitative imaging placed the protein at the nuclear envelope, most likely the inner nuclear membrane, defining the compartment in which it must act.

    Evidence Organellar proteomics enrichment scoring plus quantitative immunofluorescence microscopy in mesenchymal stem cells, adipocytes, and myocytes

    PMID:31142202

    Open questions at the time
    • Membrane topology and orientation within the inner nuclear membrane not resolved
    • No binding partners or interacting complexes identified
    • No molecular activity or pathway role established

Open questions

Synthesis pass · forward-looking unresolved questions
  • The molecular function of ARL6IP6 at the nuclear envelope remains undefined.
  • No biochemical activity assigned
  • No genetic or interaction data linking ARL6IP6 to a defined pathway
  • Functional consequence of localization to the inner nuclear membrane unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Localization
GO:0005635 nuclear envelope 1

Evidence

Reading pass · 1 per-paper finding extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2019 ARL6IP6 is concentrated at the nuclear envelope, likely residing in the inner nuclear membrane, as determined by quantitative immunofluorescence microscopy of mesenchymal stem cells, adipocytes, and myocytes using organellar proteomics enrichment scoring. Organellar proteomics (subcellular fractionation) combined with quantitative immunofluorescence microscopy Nucleus (Austin, Tex.) Medium 31142202

Source papers

Stage 0 corpus · 7 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2019 Identification of new transmembrane proteins concentrated at the nuclear envelope using organellar proteomics of mesenchymal cells. Nucleus (Austin, Tex.) 43 31142202
2011 Genome-wide association analysis of ischemic stroke in young adults. G3 (Bethesda, Md.) 30 22384361
2015 Regulation signature of miR-143 and miR-26 in porcine Salmonella infection identified by binding site enrichment analysis. Molecular genetics and genomics : MGG 18 26589421
2015 ARL6IP6, a susceptibility locus for ischemic stroke, is mutated in a patient with syndromic Cutis Marmorata Telangiectatica Congenita. Human genetics 12 25957586
2022 D155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1. Computational and structural biotechnology journal 10 35126886
2024 Cellular Organelle-Related Transcriptomic Profile Abnormalities in Neuronopathic Types of Mucopolysaccharidosis: A Comparison with Other Neurodegenerative Diseases. Current issues in molecular biology 3 38534785
2016 Mapping of a FEB3 homologous febrile seizure locus on mouse chromosome 2 containing candidate genes Scn1a and Scn3a. The European journal of neuroscience 3 27690330

Missed literature

Know a paper Affinage missed for ARL6IP6? Flag it for the maintainers and the community.

No submissions yet.